allicin has been researched along with catechin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YZ; Ung, CY | 1 |
| Czernizer, E; Dardik, A; Dardik, H; Hoffmann, T; London, D; Naftalovich, R; Orozco-Sevilla, V; Yang, C | 1 |
| Cardozo, LF; Daleprane, JB; Leite, M; Mafra, D; Pedruzzi, LM; Stenvinkel, P; Stockler-Pinto, MB | 1 |
| Avila-Carrasco, L; Díaz-Avila, DL; García-Mayorga, EA; Garza-Veloz, I; González-Mateo, GT; Martinez-Fierro, ML | 1 |
2 review(s) available for allicin and catechin
| Article | Year |
|---|---|
Nutritional strategies to modulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2.
Topics: Antioxidants; Catechin; Diet Therapy; Disulfides; Gene Expression Regulation; Humans; Inflammation; NF-E2-Related Factor 2; Resveratrol; Signal Transduction; Stilbenes; Sulfinic Acids | 2013 |
Potential Therapeutic Effects of Natural Plant Compounds in Kidney Disease.
Topics: Antioxidants; Berberine; Beta vulgaris; Betalains; Biological Products; Catechin; Curcumin; Disulfides; Flavonoids; Humans; Isothiocyanates; Kidney; Kidney Diseases; Plant Extracts; Pomegranate; Protective Agents; Resveratrol; Sulfinic Acids; Sulfoxides; Xanthophylls | 2021 |
2 other study(ies) available for allicin and catechin
| Article | Year |
|---|---|
Computer automated prediction of potential therapeutic and toxicity protein targets of bioactive compounds from Chinese medicinal plants.
Topics: Animals; Camptothecin; Catechin; China; Computer Simulation; Disulfides; Enzyme Inhibitors; Humans; Phytotherapy; Plants, Medicinal; Predictive Value of Tests; Proteins; Software; Sulfinic Acids | 2002 |
Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery.
Topics: Animals; Cardiovascular Agents; Carotid Artery Injuries; Carotid Artery, Common; Carotid Intima-Media Thickness; Catechin; Cell Proliferation; Disease Models, Animal; Disulfides; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hyperplasia; Injections, Intraperitoneal; Isothiocyanates; Male; Neointima; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Sulfinic Acids; Sulfoxides; Time Factors | 2013 |